US FDA accepts Amneal’s Biologics License Application for Bevacizumab
Bevacizumab represents the third biosimilar BLA currently filed by Amneal with the FDA
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.